NEEDHAM, Mass., Sept. 15, 2025 /PRNewswire/ -- MLAB Biosciences, a biotechnology company pioneering novel therapies for neuromuscular disease, today announced the appointment of Edward M. Kaye, M.D., ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback